FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087050942> ?p ?o ?g. }

• W3087050942 endingPage "153341" @default.
• W3087050942 startingPage "153341" @default.
• W3087050942 abstract "Curcumin (CUR) is a natural diarylheptanoid with marked anti-tumor activities. Recent investigations demonstrate that CUR combines with some other phytochemicals exerts advantages over its single application manifested as lower toxicity, higher efficacy or more significant reversal of multidrug resistance. This study aimed to elucidate a new biflavonoid (wikstroflavone B, WFB) isolated from Wikstroemia indica and to assess the synergistic inhibition of combined CUR and WFB (CUR/WFB) on human nasopharyngeal carcinoma (NPC) cell lines proliferation and metastasis. WFB was obtained through sequential chromatographic methods including silica gel, Sephadex LH-20 and preparative HPLC. Its structure was determined by HRESIMS, 1D and 2D NMR spectroscopic analysis. The absolute configuration of WFB was assigned through comparison of experimental and calculated optical rotation (OR) values. Changes in cellular viability, migration and invasion were assessed by MTT, colony formation, wound healing and Transwell assays. The nature of synergistic interaction of CUR/WFB was determined through the combination index (CI) method under the median-effect analysis. Expression levels of indicated mRNAs and proteins were measured by qRT-PCR and Western blotting assays, respectively. WFB was isolated and structural elucidated. Compared with CUR or WFB used alone, CUR/WFB treatment inhibited more effectively on the cell viability, colony formation, cell migration and invasion. Both CI and dose reduction index (DRI) values indicated the significant synergistic effects existed between CUR and WFB. Besides, CUR/WFB showed the marked modulation on the genes involved in cell proliferation (survivin, cyclin D1, p53 and p21) and metastasis (MMP-2, MMP-9 and FAK). CUR/WFB treatment was also found to restrain the phosphorylation of FAK and STAT3 proteins. When pretreatment with a FAK inhibitor, the cell viability and metastasis were significantly attenuated. The results indicate that WFB can synergistically increase the inhibitory effects of CUR on NPC cells proliferation and metastasis, and these findings may afford a rational approach for developing the antitumor medications." @default.
• W3087050942 created "2020-09-25" @default.
• W3087050942 creator A5012136264 @default.
• W3087050942 creator A5013158681 @default.
• W3087050942 creator A5030167185 @default.
• W3087050942 creator A5040118518 @default.
• W3087050942 creator A5070263135 @default.
• W3087050942 creator A5076873621 @default.
• W3087050942 date "2020-12-01" @default.
• W3087050942 modified "2023-10-01" @default.
• W3087050942 title "Curcumin and wikstroflavone B, a new biflavonoid isolated from Wikstroemia indica, synergistically suppress the proliferation and metastasis of nasopharyngeal carcinoma cells via blocking FAK/STAT3 signaling pathway" @default.
• W3087050942 cites W2045075692 @default.
• W3087050942 cites W2121410339 @default.
• W3087050942 cites W2147079987 @default.
• W3087050942 cites W2260305971 @default.
• W3087050942 cites W2336899573 @default.
• W3087050942 cites W2464824256 @default.
• W3087050942 cites W2568898976 @default.
• W3087050942 cites W2613492271 @default.
• W3087050942 cites W2624709627 @default.
• W3087050942 cites W2739970524 @default.
• W3087050942 cites W2789791583 @default.
• W3087050942 cites W2804825608 @default.
• W3087050942 cites W2811432554 @default.
• W3087050942 cites W2896423639 @default.
• W3087050942 cites W2916621234 @default.
• W3087050942 cites W2944870444 @default.
• W3087050942 cites W2982513364 @default.
• W3087050942 cites W2989515740 @default.
• W3087050942 cites W2992854503 @default.
• W3087050942 cites W2999435554 @default.
• W3087050942 cites W3006512484 @default.
• W3087050942 cites W3007470603 @default.
• W3087050942 doi "https://doi.org/10.1016/j.phymed.2020.153341" @default.
• W3087050942 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32992086" @default.
• W3087050942 hasPublicationYear "2020" @default.
• W3087050942 type Work @default.
• W3087050942 sameAs 3087050942 @default.
• W3087050942 citedByCount "14" @default.
• W3087050942 countsByYear W30870509422021 @default.
• W3087050942 countsByYear W30870509422022 @default.
• W3087050942 countsByYear W30870509422023 @default.
• W3087050942 crossrefType "journal-article" @default.
• W3087050942 hasAuthorship W3087050942A5012136264 @default.
• W3087050942 hasAuthorship W3087050942A5013158681 @default.
• W3087050942 hasAuthorship W3087050942A5030167185 @default.
• W3087050942 hasAuthorship W3087050942A5040118518 @default.
• W3087050942 hasAuthorship W3087050942A5070263135 @default.
• W3087050942 hasAuthorship W3087050942A5076873621 @default.
• W3087050942 hasConcept C126322002 @default.
• W3087050942 hasConcept C1491633281 @default.
• W3087050942 hasConcept C153911025 @default.
• W3087050942 hasConcept C185592680 @default.
• W3087050942 hasConcept C190283241 @default.
• W3087050942 hasConcept C199835354 @default.
• W3087050942 hasConcept C2775975398 @default.
• W3087050942 hasConcept C2778250585 @default.
• W3087050942 hasConcept C2778997737 @default.
• W3087050942 hasConcept C2780783641 @default.
• W3087050942 hasConcept C29537977 @default.
• W3087050942 hasConcept C502942594 @default.
• W3087050942 hasConcept C509974204 @default.
• W3087050942 hasConcept C53227056 @default.
• W3087050942 hasConcept C54355233 @default.
• W3087050942 hasConcept C55493867 @default.
• W3087050942 hasConcept C62112901 @default.
• W3087050942 hasConcept C71924100 @default.
• W3087050942 hasConcept C81885089 @default.
• W3087050942 hasConcept C86803240 @default.
• W3087050942 hasConcept C98274493 @default.
• W3087050942 hasConceptScore W3087050942C126322002 @default.
• W3087050942 hasConceptScore W3087050942C1491633281 @default.
• W3087050942 hasConceptScore W3087050942C153911025 @default.
• W3087050942 hasConceptScore W3087050942C185592680 @default.
• W3087050942 hasConceptScore W3087050942C190283241 @default.
• W3087050942 hasConceptScore W3087050942C199835354 @default.
• W3087050942 hasConceptScore W3087050942C2775975398 @default.
• W3087050942 hasConceptScore W3087050942C2778250585 @default.
• W3087050942 hasConceptScore W3087050942C2778997737 @default.
• W3087050942 hasConceptScore W3087050942C2780783641 @default.
• W3087050942 hasConceptScore W3087050942C29537977 @default.
• W3087050942 hasConceptScore W3087050942C502942594 @default.
• W3087050942 hasConceptScore W3087050942C509974204 @default.
• W3087050942 hasConceptScore W3087050942C53227056 @default.
• W3087050942 hasConceptScore W3087050942C54355233 @default.
• W3087050942 hasConceptScore W3087050942C55493867 @default.
• W3087050942 hasConceptScore W3087050942C62112901 @default.
• W3087050942 hasConceptScore W3087050942C71924100 @default.
• W3087050942 hasConceptScore W3087050942C81885089 @default.
• W3087050942 hasConceptScore W3087050942C86803240 @default.
• W3087050942 hasConceptScore W3087050942C98274493 @default.
• W3087050942 hasFunder F4320321001 @default.
• W3087050942 hasLocation W30870509421 @default.
• W3087050942 hasOpenAccess W3087050942 @default.
• W3087050942 hasPrimaryLocation W30870509421 @default.
• W3087050942 hasRelatedWork W2104115063 @default.
• W3087050942 hasRelatedWork W2185175380 @default.
• W3087050942 hasRelatedWork W2369003077 @default.

• next